Metabolites of antiarrhythmic drugs: are they clinically important?
D000813:Anilides / Q000378:metabolism / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000378:metabolism* / Q000627:therapeutic use; D004206:Disopyramide / Q000378:metabolism / Q000627:therapeutic use; D016700:Encainide; D005424:Flecainide / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D008012:Lidocaine / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use; D011342:Procainamide / Q000378:metabolism / Q000627:therapeutic use; D011802:Quinidine / Q000378:metabolism / Q000627:therapeutic use
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D008012:Lidocaine; D004206:Disopyramide; D011802:Quinidine; D005424:Flecainide; D011342:Procainamide; D016700:Encainide